Abada, P

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Acosta-Rivera, M

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Aden, K

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Adolph, T

Association of hepatic Meteorin-like and Krüppel-like factor 3 with weight loss after laporoscopic adjustable gastric banding

Adolph, TE

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Aigner, E

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Repeated episodes of severe metamizole-induced hepatotoxicity

Gastroenterologist against the machine - opportunities and limitations of machine learning models for prediction of advanced adenoma

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

PNPLA3 and TM6SF2 are neither associated with decreased cardiovascular nor increased liver-related mortality in the general population

Alber, H

The association of liver steatosis assessed by the controlled attenuated parameter and severity of liver disease with the presence of cirrhotic cardiomyopathy

Aliwa, BO

Gut Microbiome Dysbiosis, Bile acids, and Sarcopenia in Liver Cirrhosis

Alonso, Lopez S

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Antlanger, M

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

Apostol, S

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Endoskopische Raritäten

Bachmayer, S

Gastroenterologist against the machine - opportunities and limitations of machine learning models for prediction of advanced adenoma

PNPLA3 and TM6SF2 are neither associated with decreased cardiovascular nor increased liver-related mortality in the general population

Balazs, I

Gut microbiome composition in liver cirrhosis is associated with serum bile acid profile

Balcar, L

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

The impact of betablocker treatment on cancer prognosis in patients with advanced hepatocellular carcinoma receiving sorafenib treatment

PNPLA3 and TM6SF2 are neither associated with decreased cardiovascular nor increased liver-related mortality in the general population

Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Banares, R

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Bangert, C

Immediate-type hypersensitivity reaction to bulevirtide in a female patient with HBV/HDV-associated compensated cirrhosis

Baron, A

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Bartl, S

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Bauer, D

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Covered TIPS improves renal function in patients with cirrhosis and ascites

Bauer, DJ

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

Increasing ACE activity in liver disease impacts on fibrinolysis and inflammation - a potential link to COVID-19

Risk evaluation for acute kidney injury and acute-on-chronic liver failure via a blood-based biomarker panel in patients with cirrhosis

Baumgartner, N

The Phenotypic Spectrum of Patients with Genetic variants in Ceruloplasmin

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Beales, I

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Becker, J

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

Benda, M

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Berghold, A

Covid-19 and gastrointestinal manifestations: A retrospective cohort study

Bergmeister, P

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Bernhofer, S

The impact of Artificial Intelligence on the adenoma detection rate (ADR): a comparison between experienced and trainee endoscopists’ ADR

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Besuyen, R

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Bettenworth, D

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Biedermann, L

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Bijak, M

Heart rate variability in patients with irritable bowel syndrome before and after gut-directed hypnotherapy: a preliminary study.

Binder, L

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Binter, T

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Blesl, A

Gastrointestinal Bleedings are common adverse events in Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP)

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Blumberg, RS

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Böhm, V

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

Bokemeyer, B

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Bolf, D

Epidemiological trends of Hepatobiliary Carcinomas in Austria 2009-2018 - an update

Bota, S

Combined use of endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) for evaluation of obstructive jaundice and distal biliary strictures

Endoscopic ultrasound (EUS) dependent decision to perform endoscopic retrograde cholangiopancreatography (ERCP) in biliary pancreatitis without cholestasis on conventional imaging

Factors affecting the diagnostic performance of EUS-guided sampling in solid pancreatic lesions by trainee endoscopists

Red-green-blue (RGB) profiling of pancreatic mass-elastographies: validation of a predictive model for non-invasive assessment of malignancy

Bacterial spectrum and antibiotic resistance in patients with spontaneous bacterial peritonitis in southern Austria

Combination of TACE plus RFA in early and intermediate stage HCC patients

Epidemiological trends of Hepatobiliary Carcinomas in Austria 2009-2018 - an update

Der Effekt einer chronischen Statintherapie auf das Risikoeiner post-ERCP Pankreatitis mit bzw. ohne rektaler periprozeduraler NSAR-Therapie

Value of Hitachi Shear Wave Elastography (SWE) to rule-in and rule-out the presence of esophageal varices in patients with compensated advanced liver disease

The association of liver steatosis assessed by the controlled attenuated parameter and severity of liver disease with the presence of cirrhotic cardiomyopathy

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Braithwaite, VS

Bone marker response to intravenous iron treatment - an in vitro model

Braunwarth, E

IL-37 - a regulation relevant cytokine in liver regeneration?

Bretthauer, M

Assoziation der Adenomentdeckungsrate und Charakteristika abgetragener Adenome mit der Mortalität des kolorektalen Karzinoms nach einer Vordorgekoloskopie

Bucsics, T

The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Caparrós, E

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Chan, S

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Chromy, D

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Immediate-type hypersensitivity reaction to bulevirtide in a female patient with HBV/HDV-associated compensated cirrhosis

Chung Cheung Yau, T

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Crevenna, R

Heart rate variability in patients with irritable bowel syndrome before and after gut-directed hypnotherapy: a preliminary study.

Danese, S

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Danzinger, D

Endoskopische Raritäten

Datz, C

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Gastroenterologist against the machine - opportunities and limitations of machine learning models for prediction of advanced adenoma

NAFLD is not independently associated with H. pylori in an Austrian screening collective

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

PNPLA3 and TM6SF2 are neither associated with decreased cardiovascular nor increased liver-related mortality in the general population

Datz, L

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

Dax, K

Listeria-associated multiple granulomatous liver abscesses complicated by vena cava inferior thrombosis

COVID-19 vaccination in patients with autoimmune hepatitis

COVID19 vaccination in liver transplant recipients

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Dejaco, C

Heart rate variability in patients with irritable bowel syndrome before and after gut-directed hypnotherapy: a preliminary study.

De Toni, E

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Dinkhauser, P

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Dorn, L

Secondary Sclerosing Cholangitis of the Critically Ill Patient suffering from COVID19

Dossa, SDe

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Duller, C

ERCP in Österreich: Hat die Zentrumsgröße Einfluss auf Erfolgs- und Komplikationsraten?

Ebert, MP

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Ecker, D

Ustekinumab bei Colitis ulcerosa - Real-world experience

Edlinger, DP

Der Effekt einer chronischen Statintherapie auf das Risikoeiner post-ERCP Pankreatitis mit bzw. ohne rektaler periprozeduraler NSAR-Therapie

Effenberger, M

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Association of hepatic Meteorin-like and Krüppel-like factor 3 with weight loss after laporoscopic adjustable gastric banding

Egger, M

PNPLA3 and TM6SF2 are neither associated with decreased cardiovascular nor increased liver-related mortality in the general population

Eibisberger, M

Gastrointestinal Bleedings are common adverse events in Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP)

Eigenbauer, E

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Eller, P

Impact of COVID-19 on rare diseases: Report of three cases of acute hepatic porphyria affected by the pandemic

Enrich, B

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Association of hepatic Meteorin-like and Krüppel-like factor 3 with weight loss after laporoscopic adjustable gastric banding

Epping, H

Flexible endoskopische Therapie des Zenker Divertikels

Essler, G

Combined use of endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) for evaluation of obstructive jaundice and distal biliary strictures

Endoscopic ultrasound (EUS) dependent decision to perform endoscopic retrograde cholangiopancreatography (ERCP) in biliary pancreatitis without cholestasis on conventional imaging

Factors affecting the diagnostic performance of EUS-guided sampling in solid pancreatic lesions by trainee endoscopists

Red-green-blue (RGB) profiling of pancreatic mass-elastographies: validation of a predictive model for non-invasive assessment of malignancy

Der Effekt einer chronischen Statintherapie auf das Risikoeiner post-ERCP Pankreatitis mit bzw. ohne rektaler periprozeduraler NSAR-Therapie

Fauler, G

Gut microbiome composition in liver cirrhosis is associated with serum bile acid profile

Feagan, BC

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Feagan, BG

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Feichtenschlager, T

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Feldbacher, N

Gut Microbiome Dysbiosis, Bile acids, and Sarcopenia in Liver Cirrhosis

Gut microbiome composition in liver cirrhosis is associated with serum bile acid profile

Feldman, A

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

Ferenci, P

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Ferlitsch, M

Neue Risikostratifizierung nach kolorektaler Polypektomie reduziert die Bürde an Nachsorekoloskopien ohne die Mortalität zu erhöhen

Assoziation der Adenomentdeckungsrate und Charakteristika abgetragener Adenome mit der Mortalität des kolorektalen Karzinoms nach einer Vordorgekoloskopie

Filip, R

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Finkelmeier, F

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Finn, R

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Flasch-Polly, C

Repeated episodes of severe metamizole-induced hepatotoxicity

Fogel, R

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Francés, R

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Fraunberger, P

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Frece, NJ

Covid-19 and gastrointestinal manifestations: A retrospective cohort study

Frick, C

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Fritz, T

Perorale endoskopische Myotomie am Ordensklinikum Linz

Fuchssteiner, H

Ustekinumab bei Colitis ulcerosa - Real-world experience

Fürstner, M

Combination of TACE plus RFA in early and intermediate stage HCC patients

Galle, P

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Gatterer, L

Diet in alcohol withdrawal - coffee consumption is associated with reduced risk of alcohol-induced liver fibrosis and steatosis

Liver and heart fibrosis develops simultaneously in patients with alcohol use disorder - a preliminary report of the HALFWAY study

Gaumann, A

Landscape of biomarkers and actionable gene alterations in adenocarcinoma of GEJ and stomach - A real-world data analysis

Genesca, J

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Gensluckner, S

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Repeated episodes of severe metamizole-induced hepatotoxicity

Gerner, RR

A risk variant within the ‘interferon induced with helicase C domain 1ʹ (IFIH1) gene render epithelial cells susceptible for microbial stimuli

Geroldinger-Simic, M

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Gesierich, FJ

Bacterial spectrum and antibiotic resistance in patients with spontaneous bacterial peritonitis in southern Austria

Gessl, I

Neue Risikostratifizierung nach kolorektaler Polypektomie reduziert die Bürde an Nachsorekoloskopien ohne die Mortalität zu erhöhen

Assoziation der Adenomentdeckungsrate und Charakteristika abgetragener Adenome mit der Mortalität des kolorektalen Karzinoms nach einer Vordorgekoloskopie

Goyal, L

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Grabher, C

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Grabherr, F

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

IL-37 - a regulation relevant cytokine in liver regeneration?

Association of hepatic Meteorin-like and Krüppel-like factor 3 with weight loss after laporoscopic adjustable gastric banding

Graf, R

Endoskopische Raritäten

Grander, C

IL-37 - a regulation relevant cytokine in liver regeneration?

Diet in alcohol withdrawal - coffee consumption is associated with reduced risk of alcohol-induced liver fibrosis and steatosis

Association of hepatic Meteorin-like and Krüppel-like factor 3 with weight loss after laporoscopic adjustable gastric banding

Liver and heart fibrosis develops simultaneously in patients with alcohol use disorder - a preliminary report of the HALFWAY study

Grander, W

Diet in alcohol withdrawal - coffee consumption is associated with reduced risk of alcohol-induced liver fibrosis and steatosis

Liver and heart fibrosis develops simultaneously in patients with alcohol use disorder - a preliminary report of the HALFWAY study

Graw, J

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Gregus, M

Ustekinumab bei Colitis ulcerosa - Real-world experience

Gröchenig, H

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Seltene Ursache eines schweren enteralen Eiweißverlustsyndroms

Gronich-Wondrak, P

Bone marker response to intravenous iron treatment - an in vitro model

Grossgut, M

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Grünberger, T

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Covered TIPS improves renal function in patients with cirrhosis and ascites

Gschwantler, M

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

VICI-REG - Vienna Cirrhosis registry: A retrospective, epidemiological analysis of cirrhostic patients at a tertiary care center in Vienna, Austria. Preliminary results

Immediate-type hypersensitivity reaction to bulevirtide in a female patient with HBV/HDV-associated compensated cirrhosis

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Günther, J

IL-37 - a regulation relevant cytokine in liver regeneration?

Haas, T

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Hackl, G

Impact of COVID-19 on rare diseases: Report of three cases of acute hepatic porphyria affected by the pandemic

Hackl, M

The association of liver steatosis assessed by the controlled attenuated parameter and severity of liver disease with the presence of cirrhotic cardiomyopathy

Hametner-Schreil, S

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Lebertransplantation bei HCC - ein Follow-up am Ordensklinikum Linz in Hinblick auf Transplantationskriterien und Outcome

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Hartl, C

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Hartl, L

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Increasing ACE activity in liver disease impacts on fibrinolysis and inflammation - a potential link to COVID-19

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Covered TIPS improves renal function in patients with cirrhosis and ascites

Risk evaluation for acute kidney injury and acute-on-chronic liver failure via a blood-based biomarker panel in patients with cirrhosis

Hartmann, B

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Hartmann, P

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Hausegger, K

Combination of TACE plus RFA in early and intermediate stage HCC patients

He, A

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Hempel, D

Landscape of biomarkers and actionable gene alterations in adenocarcinoma of GEJ and stomach - A real-world data analysis

Hempel, L

Landscape of biomarkers and actionable gene alterations in adenocarcinoma of GEJ and stomach - A real-world data analysis

Henninger, B

The Phenotypic Spectrum of Patients with Genetic variants in Ceruloplasmin

Hennlich, B

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Hibi, T

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Hinterberger, A

Neue Risikostratifizierung nach kolorektaler Polypektomie reduziert die Bürde an Nachsorekoloskopien ohne die Mortalität zu erhöhen

Assoziation der Adenomentdeckungsrate und Charakteristika abgetragener Adenome mit der Mortalität des kolorektalen Karzinoms nach einer Vordorgekoloskopie

Hinternberger, R

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

Hofer, BS

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Hofer, H

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Högenauer, C

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Holzmann, H

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Hoppe, S

Endoskopische Raritäten

Horhat, A

Histological lesions can predict response to corticosteroids in patients with severe alcohol-related steatohepatitis

Horvath, A

Impact of COVID-19 on rare diseases: Report of three cases of acute hepatic porphyria affected by the pandemic

Gut Microbiome Dysbiosis, Bile acids, and Sarcopenia in Liver Cirrhosis

Covid-19 and gastrointestinal manifestations: A retrospective cohort study

Gut microbiome composition in liver cirrhosis is associated with serum bile acid profile

Hospodarskyy, I

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Hoyer, P

Retrospektive Analyse der fäkalen Mikrobiotatransfers bei Clostridium-difficile-Infektion und Colitis ulcerosa am Ordensklinikum Linz

Hsu, C

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Hübl, W

VICI-REG - Vienna Cirrhosis registry: A retrospective, epidemiological analysis of cirrhostic patients at a tertiary care center in Vienna, Austria. Preliminary results

Hucke, F

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Bacterial spectrum and antibiotic resistance in patients with spontaneous bacterial peritonitis in southern Austria

Combination of TACE plus RFA in early and intermediate stage HCC patients

Epidemiological trends of Hepatobiliary Carcinomas in Austria 2009-2018 - an update

Value of Hitachi Shear Wave Elastography (SWE) to rule-in and rule-out the presence of esophageal varices in patients with compensated advanced liver disease

Illiasch, C

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Itzlinger-Monshi, B

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Jachs, M

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation

Immediate-type hypersensitivity reaction to bulevirtide in a female patient with HBV/HDV-associated compensated cirrhosis

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Increasing ACE activity in liver disease impacts on fibrinolysis and inflammation - a potential link to COVID-19

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Covered TIPS improves renal function in patients with cirrhosis and ascites

Risk evaluation for acute kidney injury and acute-on-chronic liver failure via a blood-based biomarker panel in patients with cirrhosis

Jager, M

Histological lesions can predict response to corticosteroids in patients with severe alcohol-related steatohepatitis

Janecke, A

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Johannes, J

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Jonas, JP

Covered TIPS improves renal function in patients with cirrhosis and ascites

Jud, P

Impact of COVID-19 on rare diseases: Report of three cases of acute hepatic porphyria affected by the pandemic

Kaiser, C

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Kammerlander, A

Neue Risikostratifizierung nach kolorektaler Polypektomie reduziert die Bürde an Nachsorekoloskopien ohne die Mortalität zu erhöhen

Assoziation der Adenomentdeckungsrate und Charakteristika abgetragener Adenome mit der Mortalität des kolorektalen Karzinoms nach einer Vordorgekoloskopie

Kaneider, NC

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Kapral, C

ERCP in Österreich: Hat die Zentrumsgröße Einfluss auf Erfolgs- und Komplikationsraten?

Diarrhoe mit metabolischer Alkalose - gibt es nicht? Gibt es! Ein Fallbericht

Kargl, S

Familiäre und hereditäre Pankreatitis

Karnel, F

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Covered TIPS improves renal function in patients with cirrhosis and ascites

Karner, J

Covered TIPS improves renal function in patients with cirrhosis and ascites

Karsdal, M

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Kaser, A

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Kazemi-Shirazi, L

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Keip, B

Heart rate variability in patients with irritable bowel syndrome before and after gut-directed hypnotherapy: a preliminary study.

Kempinski, R

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Kessler, H

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Kiechl, SJ

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

Kienbauer, M

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Ustekinumab bei Colitis ulcerosa - Real-world experience

Familiäre und hereditäre Pankreatitis

Kienzl-Wagner, K

IL-37 - a regulation relevant cytokine in liver regeneration?

Kim, H

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Kim, S

Initial Clearance of Infliximab is a predictor for the time of formation of anti-drug antibodies.

Initial Clearance of Infliximab is a predictor for long-time mucosal healing and biomarker response

Kimpel, J

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

Kirstein, MM

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Klivinyi, C

Gastrointestinal Bleedings are common adverse events in Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP)

Kloucek, W

Epidemiological overview of chronic pancreatitis in the northeast of Austria

Knaus, A

Combination of TACE plus RFA in early and intermediate stage HCC patients

Koch, R

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

Koch, S

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

König, K

Endoskopische Raritäten

Kozbial, K

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Kozsar, A

A risk variant within the ‘interferon induced with helicase C domain 1ʹ (IFIH1) gene render epithelial cells susceptible for microbial stimuli

Kramer, L

Endoskopische Raritäten

Kump, P

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Kutilek, M

Factors affecting the diagnostic performance of EUS-guided sampling in solid pancreatic lesions by trainee endoscopists

Kutschera, M

Initial Clearance of Infliximab is a predictor for the time of formation of anti-drug antibodies.

Initial Clearance of Infliximab is a predictor for long-time mucosal healing and biomarker response

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Kütting, F

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Lackner, C

Histological lesions can predict response to corticosteroids in patients with severe alcohol-related steatohepatitis

Laferl, H

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Lampichler, K

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Längle, J

Beeinflussung des intestinalen Mikrobioms durch ein Extrakt der schwarzen Holunderbeere - Ergebnisse der ELDERGUT Studie

Langner, C

Seltene Ursache eines schweren enteralen Eiweißverlustsyndroms

Leber, B

Gut microbiome composition in liver cirrhosis is associated with serum bile acid profile

Lee, J

Initial Clearance of Infliximab is a predictor for the time of formation of anti-drug antibodies.

Initial Clearance of Infliximab is a predictor for long-time mucosal healing and biomarker response

Lee, S

Initial Clearance of Infliximab is a predictor for the time of formation of anti-drug antibodies.

Initial Clearance of Infliximab is a predictor for long-time mucosal healing and biomarker response

Leeming, D

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Lens, S

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Lind, T

Covid-19 and gastrointestinal manifestations: A retrospective cohort study

Lindorfer, A

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Lisman, T

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

Liu, X

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Loacker, L

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Loftus, EV

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Loschko, N

Listeria-associated multiple granulomatous liver abscesses complicated by vena cava inferior thrombosis

Ludwiczek, O

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Macheiner, S

A risk variant within the ‘interferon induced with helicase C domain 1ʹ (IFIH1) gene render epithelial cells susceptible for microbial stimuli

Einfluss von Inflammation auf zelluläre und systemische Pharmakokinetik von Tofacitinib

Maier, H

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Maieron, A

ERCP in Österreich: Hat die Zentrumsgröße Einfluss auf Erfolgs- und Komplikationsraten?

Factors affecting the diagnostic performance of EUS-guided sampling in solid pancreatic lesions by trainee endoscopists

Flexible endoskopische Therapie des Zenker Divertikels

Epidemiological overview of chronic pancreatitis in the northeast of Austria

The influence of gender on the risk factors of acute pancreatitis in northeastern Austria

Secondary Sclerosing Cholangitis of the Critically Ill Patient suffering from COVID19

Majcher, B

Neue Risikostratifizierung nach kolorektaler Polypektomie reduziert die Bürde an Nachsorekoloskopien ohne die Mortalität zu erhöhen

Assoziation der Adenomentdeckungsrate und Charakteristika abgetragener Adenome mit der Mortalität des kolorektalen Karzinoms nach einer Vordorgekoloskopie

Mamandipoor, B

Gastroenterologist against the machine - opportunities and limitations of machine learning models for prediction of advanced adenoma

Mandorfer, M

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

VICI-REG - Vienna Cirrhosis registry: A retrospective, epidemiological analysis of cirrhostic patients at a tertiary care center in Vienna, Austria. Preliminary results

Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Increasing ACE activity in liver disease impacts on fibrinolysis and inflammation - a potential link to COVID-19

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

The impact of betablocker treatment on cancer prognosis in patients with advanced hepatocellular carcinoma receiving sorafenib treatment

Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Covered TIPS improves renal function in patients with cirrhosis and ascites

Risk evaluation for acute kidney injury and acute-on-chronic liver failure via a blood-based biomarker panel in patients with cirrhosis

Manzano, ML

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Marculescu, R

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Marksteiner, J

Diet in alcohol withdrawal - coffee consumption is associated with reduced risk of alcohol-induced liver fibrosis and steatosis

Liver and heart fibrosis develops simultaneously in patients with alcohol use disorder - a preliminary report of the HALFWAY study

Massl, R

Endoskopische Raritäten

Mattes, S

Epidemiological overview of chronic pancreatitis in the northeast of Austria

The influence of gender on the risk factors of acute pancreatitis in northeastern Austria

Mauler, H

Endoskopische Raritäten

Mayer, A

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Secondary Sclerosing Cholangitis of the Critically Ill Patient suffering from COVID19

Mayr, L

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Association of hepatic Meteorin-like and Krüppel-like factor 3 with weight loss after laporoscopic adjustable gastric banding

McNally, J

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Mehta, R

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Meierhofer, CV

ERCP in Österreich: Hat die Zentrumsgröße Einfluss auf Erfolgs- und Komplikationsraten?

Diarrhoe mit metabolischer Alkalose - gibt es nicht? Gibt es! Ein Fallbericht

Meischl, T

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

The impact of betablocker treatment on cancer prognosis in patients with advanced hepatocellular carcinoma receiving sorafenib treatment

Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib

Mertens, JC

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Meyer, EL

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Meyer, M

Association of hepatic Meteorin-like and Krüppel-like factor 3 with weight loss after laporoscopic adjustable gastric banding

Miehsler, W

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Moschen, A

IL-37 - a regulation relevant cytokine in liver regeneration?

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

Beeinflussung des intestinalen Mikrobioms durch ein Extrakt der schwarzen Holunderbeere - Ergebnisse der ELDERGUT Studie

COVID19 vaccination in liver transplant recipients

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Einfluss von Inflammation auf zelluläre und systemische Pharmakokinetik von Tofacitinib

Moschen, AR

Safety and efficacy of the mRNA-1273 SARS-CoV-2 vaccine in a cohort of patients with inflammatory bowel disease

A risk variant within the ‘interferon induced with helicase C domain 1ʹ (IFIH1) gene render epithelial cells susceptible for microbial stimuli

Listeria-associated multiple granulomatous liver abscesses complicated by vena cava inferior thrombosis

COVID-19 vaccination in patients with autoimmune hepatitis

Moser, G

Heart rate variability in patients with irritable bowel syndrome before and after gut-directed hypnotherapy: a preliminary study.

Mould, D

Initial Clearance of Infliximab is a predictor for the time of formation of anti-drug antibodies.

Initial Clearance of Infliximab is a predictor for long-time mucosal healing and biomarker response

Müller, C

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

The impact of betablocker treatment on cancer prognosis in patients with advanced hepatocellular carcinoma receiving sorafenib treatment

Müller, CJ

Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib

Müllner-Bucsics, TA

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Covered TIPS improves renal function in patients with cirrhosis and ascites

Munda, P

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Mutschlechner, B

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Nguyen, A

IL-37 - a regulation relevant cytokine in liver regeneration?

Niederreiter, L

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Niederseer, D

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

PNPLA3 and TM6SF2 are neither associated with decreased cardiovascular nor increased liver-related mortality in the general population

Nijhawan, S

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Nikolajevic, A

IL-37 - a regulation relevant cytokine in liver regeneration?

Novacek, G

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Initial Clearance of Infliximab is a predictor for the time of formation of anti-drug antibodies.

Initial Clearance of Infliximab is a predictor for long-time mucosal healing and biomarker response

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Nussbaumer, RJ

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Oberacher, H

Einfluss von Inflammation auf zelluläre und systemische Pharmakokinetik von Tofacitinib

Oberhuber, G

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Oberkofler, H

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

Oberleitner, K

Zöliakie: vom Symptom zur Diagnose

Obholzer, L

Bone marker response to intravenous iron treatment - an in vitro model

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Ofenbeck-Barborka, E

Endoskopische Raritäten

Osmani, V

Gastroenterologist against the machine - opportunities and limitations of machine learning models for prediction of advanced adenoma

Palma, S

Heart rate variability in patients with irritable bowel syndrome before and after gut-directed hypnotherapy: a preliminary study.

Panzer, M

The Phenotypic Spectrum of Patients with Genetic variants in Ceruloplasmin

Paternostro, R

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Paulweber, B

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

Peck-Radosavljevic, M

Combined use of endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) for evaluation of obstructive jaundice and distal biliary strictures

Endoscopic ultrasound (EUS) dependent decision to perform endoscopic retrograde cholangiopancreatography (ERCP) in biliary pancreatitis without cholestasis on conventional imaging

Factors affecting the diagnostic performance of EUS-guided sampling in solid pancreatic lesions by trainee endoscopists

Red-green-blue (RGB) profiling of pancreatic mass-elastographies: validation of a predictive model for non-invasive assessment of malignancy

Bacterial spectrum and antibiotic resistance in patients with spontaneous bacterial peritonitis in southern Austria

Combination of TACE plus RFA in early and intermediate stage HCC patients

Epidemiological trends of Hepatobiliary Carcinomas in Austria 2009-2018 - an update

Der Effekt einer chronischen Statintherapie auf das Risikoeiner post-ERCP Pankreatitis mit bzw. ohne rektaler periprozeduraler NSAR-Therapie

Value of Hitachi Shear Wave Elastography (SWE) to rule-in and rule-out the presence of esophageal varices in patients with compensated advanced liver disease

The association of liver steatosis assessed by the controlled attenuated parameter and severity of liver disease with the presence of cirrhotic cardiomyopathy

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Pedrini, A

Association of hepatic Meteorin-like and Krüppel-like factor 3 with weight loss after laporoscopic adjustable gastric banding

Penner, A

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

COVID-19 vaccination in patients with autoimmune hepatitis

COVID19 vaccination in liver transplant recipients

Penz, D

Neue Risikostratifizierung nach kolorektaler Polypektomie reduziert die Bürde an Nachsorekoloskopien ohne die Mortalität zu erhöhen

Assoziation der Adenomentdeckungsrate und Charakteristika abgetragener Adenome mit der Mortalität des kolorektalen Karzinoms nach einer Vordorgekoloskopie

Pertler, E

The Phenotypic Spectrum of Patients with Genetic variants in Ceruloplasmin

Peter, J

Heart rate variability in patients with irritable bowel syndrome before and after gut-directed hypnotherapy: a preliminary study.

Peters, P

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Peyrin-Biroulet, L

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Pfister, A

IL-37 - a regulation relevant cytokine in liver regeneration?

Beeinflussung des intestinalen Mikrobioms durch ein Extrakt der schwarzen Holunderbeere - Ergebnisse der ELDERGUT Studie

Einfluss von Inflammation auf zelluläre und systemische Pharmakokinetik von Tofacitinib

Philipp, M

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Philipp, P

Landscape of biomarkers and actionable gene alterations in adenocarcinoma of GEJ and stomach - A real-world data analysis

Pimingstorfer, P

Safety and efficacy of the mRNA-1273 SARS-CoV-2 vaccine in a cohort of patients with inflammatory bowel disease

Short-term outcome and safety of peroral endoscopic myotomy for treating achalasia in a university hospital in Austria

Outcomes and safety of endoscopic submucosa dissection at a university clinic in Austria

Pinato, DJ

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Pinter, M

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

Epidemiological trends of Hepatobiliary Carcinomas in Austria 2009-2018 - an update

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

The impact of betablocker treatment on cancer prognosis in patients with advanced hepatocellular carcinoma receiving sorafenib treatment

Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Pinter non-author presenter, M

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Pircher, A

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Piribauer, M

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Piringer, P

Ustekinumab bei Colitis ulcerosa - Real-world experience

Plachta-Danielzik, S

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Plaikner, M

The Phenotypic Spectrum of Patients with Genetic variants in Ceruloplasmin

Plattner, S

Beeinflussung des intestinalen Mikrobioms durch ein Extrakt der schwarzen Holunderbeere - Ergebnisse der ELDERGUT Studie

Pomej, K

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

The impact of betablocker treatment on cancer prognosis in patients with advanced hepatocellular carcinoma receiving sorafenib treatment

Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Pons, M

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Pramhofer, P

Secondary Sclerosing Cholangitis of the Critically Ill Patient suffering from COVID19

Primas, C

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Initial Clearance of Infliximab is a predictor for the time of formation of anti-drug antibodies.

Initial Clearance of Infliximab is a predictor for long-time mucosal healing and biomarker response

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Primavesi, F

IL-37 - a regulation relevant cytokine in liver regeneration?

Prommer, R

Familiäre und hereditäre Pankreatitis

Prosenz, J

The influence of gender on the risk factors of acute pancreatitis in northeastern Austria

Przysiecki, N

A risk variant within the ‘interferon induced with helicase C domain 1ʹ (IFIH1) gene render epithelial cells susceptible for microbial stimuli

Beeinflussung des intestinalen Mikrobioms durch ein Extrakt der schwarzen Holunderbeere - Ergebnisse der ELDERGUT Studie

Quehenberger, P

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Radu, P

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Rahbari, NN

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Rainer, B

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Rainer, F

Histological lesions can predict response to corticosteroids in patients with severe alcohol-related steatohepatitis

Ran, Q

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Rautou, P

Histological lesions can predict response to corticosteroids in patients with severe alcohol-related steatohepatitis

Razpotnik, M

Combined use of endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) for evaluation of obstructive jaundice and distal biliary strictures

Endoscopic ultrasound (EUS) dependent decision to perform endoscopic retrograde cholangiopancreatography (ERCP) in biliary pancreatitis without cholestasis on conventional imaging

Factors affecting the diagnostic performance of EUS-guided sampling in solid pancreatic lesions by trainee endoscopists

Red-green-blue (RGB) profiling of pancreatic mass-elastographies: validation of a predictive model for non-invasive assessment of malignancy

Der Effekt einer chronischen Statintherapie auf das Risikoeiner post-ERCP Pankreatitis mit bzw. ohne rektaler periprozeduraler NSAR-Therapie

Value of Hitachi Shear Wave Elastography (SWE) to rule-in and rule-out the presence of esophageal varices in patients with compensated advanced liver disease

The association of liver steatosis assessed by the controlled attenuated parameter and severity of liver disease with the presence of cirrhotic cardiomyopathy

Reiberger, T

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

VICI-REG - Vienna Cirrhosis registry: A retrospective, epidemiological analysis of cirrhostic patients at a tertiary care center in Vienna, Austria. Preliminary results

Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Increasing ACE activity in liver disease impacts on fibrinolysis and inflammation - a potential link to COVID-19

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

The impact of betablocker treatment on cancer prognosis in patients with advanced hepatocellular carcinoma receiving sorafenib treatment

Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Covered TIPS improves renal function in patients with cirrhosis and ascites

Risk evaluation for acute kidney injury and acute-on-chronic liver failure via a blood-based biomarker panel in patients with cirrhosis

Reibergern, T

Immediate-type hypersensitivity reaction to bulevirtide in a female patient with HBV/HDV-associated compensated cirrhosis

Reichmayr, M

Endoskopische Raritäten

Reicht, G

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Reider, S

IL-37 - a regulation relevant cytokine in liver regeneration?

Einfluss von Inflammation auf zelluläre und systemische Pharmakokinetik von Tofacitinib

Reider, SJ

Beeinflussung des intestinalen Mikrobioms durch ein Extrakt der schwarzen Holunderbeere - Ergebnisse der ELDERGUT Studie

Reinisch, S

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Initial Clearance of Infliximab is a predictor for the time of formation of anti-drug antibodies.

Initial Clearance of Infliximab is a predictor for long-time mucosal healing and biomarker response

Reinisch, W

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Initial Clearance of Infliximab is a predictor for the time of formation of anti-drug antibodies.

Initial Clearance of Infliximab is a predictor for long-time mucosal healing and biomarker response

Reinstadler, V

Einfluss von Inflammation auf zelluläre und systemische Pharmakokinetik von Tofacitinib

Reisinger, AC

Impact of COVID-19 on rare diseases: Report of three cases of acute hepatic porphyria affected by the pandemic

Reiter, S

Listeria-associated multiple granulomatous liver abscesses complicated by vena cava inferior thrombosis

COVID-19 vaccination in patients with autoimmune hepatitis

COVID19 vaccination in liver transplant recipients

Reiter, V

Lebertransplantation bei HCC - ein Follow-up am Ordensklinikum Linz in Hinblick auf Transplantationskriterien und Outcome

Riederer, M

Diet in alcohol withdrawal - coffee consumption is associated with reduced risk of alcohol-induced liver fibrosis and steatosis

Liver and heart fibrosis develops simultaneously in patients with alcohol use disorder - a preliminary report of the HALFWAY study

Ritter, T

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Robert, S

Landscape of biomarkers and actionable gene alterations in adenocarcinoma of GEJ and stomach - A real-world data analysis

Rodriguez-Tajes, S

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Rogler, G

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Rosenkranz, M

Seltene Ursache eines schweren enteralen Eiweißverlustsyndroms

Rosenstiel, P

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Rössler, A

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

Rugani, P

Zahnärztliche Herdsanierung vor Lebertransplantation - eine retrospektive Studie

Russo, FP

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Sandborn, WJ

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Santonja, I

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Schaefer, B

Risk factors for and effects of persistent and severe hypophosphataemia following ferric carboxymaltose: Secondary analysis of randomised clinical trials

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Schäfer, B

The Phenotypic Spectrum of Patients with Genetic variants in Ceruloplasmin

Bone marker response to intravenous iron treatment - an in vitro model

Schatz, UA

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Scheiner, B

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Increasing ACE activity in liver disease impacts on fibrinolysis and inflammation - a potential link to COVID-19

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

The impact of betablocker treatment on cancer prognosis in patients with advanced hepatocellular carcinoma receiving sorafenib treatment

Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Schimetta, W

Flexible endoskopische Therapie des Zenker Divertikels

Schmidbauer, C

VICI-REG - Vienna Cirrhosis registry: A retrospective, epidemiological analysis of cirrhostic patients at a tertiary care center in Vienna, Austria. Preliminary results

Immediate-type hypersensitivity reaction to bulevirtide in a female patient with HBV/HDV-associated compensated cirrhosis

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Schneeberger, S

IL-37 - a regulation relevant cytokine in liver regeneration?

Schoder, M

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Covered TIPS improves renal function in patients with cirrhosis and ascites

Schöfl, R

Ustekinumab bei Colitis ulcerosa - Real-world experience

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Familiäre und hereditäre Pankreatitis

Retrospektive Analyse der fäkalen Mikrobiotatransfers bei Clostridium-difficile-Infektion und Colitis ulcerosa am Ordensklinikum Linz

Perorale endoskopische Myotomie am Ordensklinikum Linz

Flexible endoskopische Therapie des Zenker Divertikels

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Lebertransplantation bei HCC - ein Follow-up am Ordensklinikum Linz in Hinblick auf Transplantationskriterien und Outcome

Schönhofer, K

Covered TIPS improves renal function in patients with cirrhosis and ascites

Schörghuber, M

Gastrointestinal Bleedings are common adverse events in Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP)

Schreiber, S

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Schultz, C

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Schulze, K

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Schwabegger, C

IL-37 - a regulation relevant cytokine in liver regeneration?

Schwabl, P

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Schwarz, M

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

VICI-REG - Vienna Cirrhosis registry: A retrospective, epidemiological analysis of cirrhostic patients at a tertiary care center in Vienna, Austria. Preliminary results

Immediate-type hypersensitivity reaction to bulevirtide in a female patient with HBV/HDV-associated compensated cirrhosis

Schwärzler, J

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Association of hepatic Meteorin-like and Krüppel-like factor 3 with weight loss after laporoscopic adjustable gastric banding

Seemann, C

Endoskopische Raritäten

Seibold, F

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Seidler, U

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Semmler, G

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Gastroenterologist against the machine - opportunities and limitations of machine learning models for prediction of advanced adenoma

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

NAFLD is not independently associated with H. pylori in an Austrian screening collective

Increasing ACE activity in liver disease impacts on fibrinolysis and inflammation - a potential link to COVID-19

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

PNPLA3 and TM6SF2 are neither associated with decreased cardiovascular nor increased liver-related mortality in the general population

Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Risk evaluation for acute kidney injury and acute-on-chronic liver failure via a blood-based biomarker panel in patients with cirrhosis

Semmler, L

Gastroenterologist against the machine - opportunities and limitations of machine learning models for prediction of advanced adenoma

Semmler, M

PNPLA3 and TM6SF2 are neither associated with decreased cardiovascular nor increased liver-related mortality in the general population

Siebenhüner, AR

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Siebert, F

Seltene Ursache eines schweren enteralen Eiweißverlustsyndroms

Sigl, C

Endoskopische Raritäten

Simbrunner, B

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Increasing ACE activity in liver disease impacts on fibrinolysis and inflammation - a potential link to COVID-19

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Risk evaluation for acute kidney injury and acute-on-chronic liver failure via a blood-based biomarker panel in patients with cirrhosis

Söllradl, I

Diarrhoe mit metabolischer Alkalose - gibt es nicht? Gibt es! Ein Fallbericht

Sonneck, K

Impact of skin examination prior to initiation of treatment with biologics in Inflammatory Bowel Disease patients: preliminary data

Spahn, S

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Spaun, G

Perorale endoskopische Myotomie am Ordensklinikum Linz

Flexible endoskopische Therapie des Zenker Divertikels

Sprung, S

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Stadlbauer, V

Gastrointestinal Bleedings are common adverse events in Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP)

Impact of COVID-19 on rare diseases: Report of three cases of acute hepatic porphyria affected by the pandemic

Gut microbiome composition in liver cirrhosis is associated with serum bile acid profile

Stadlbauer-Köllner, V

Zahnärztliche Herdsanierung vor Lebertransplantation - eine retrospektive Studie

Gut Microbiome Dysbiosis, Bile acids, and Sarcopenia in Liver Cirrhosis

Covid-19 and gastrointestinal manifestations: A retrospective cohort study

Stampfel, G

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

COVID19 vaccination in liver transplant recipients

Stättermayer, A

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Stättermayer, AF

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

Stauber, R

Histological lesions can predict response to corticosteroids in patients with severe alcohol-related steatohepatitis

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Stefanescu, H

Histological lesions can predict response to corticosteroids in patients with severe alcohol-related steatohepatitis

Stehrer, R

Zahnärztliche Herdsanierung vor Lebertransplantation - eine retrospektive Studie

Steidl, K

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Seltene Ursache eines schweren enteralen Eiweißverlustsyndroms

Steiner, E

Epidemiological overview of chronic pancreatitis in the northeast of Austria

The influence of gender on the risk factors of acute pancreatitis in northeastern Austria

Steiner, P

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Stickel, F

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

Stirnimann, G

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Strasser, M

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

Sturm, S

Beeinflussung des intestinalen Mikrobioms durch ein Extrakt der schwarzen Holunderbeere - Ergebnisse der ELDERGUT Studie

Tappe, U

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Tasset, C

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Teufel, A

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Texler, B

Einfluss von Inflammation auf zelluläre und systemische Pharmakokinetik von Tofacitinib

Tilg, H

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Beeinflussung des intestinalen Mikrobioms durch ein Extrakt der schwarzen Holunderbeere - Ergebnisse der ELDERGUT Studie

The Phenotypic Spectrum of Patients with Genetic variants in Ceruloplasmin

Diet in alcohol withdrawal - coffee consumption is associated with reduced risk of alcohol-induced liver fibrosis and steatosis

Bone marker response to intravenous iron treatment - an in vitro model

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Einfluss von Inflammation auf zelluläre und systemische Pharmakokinetik von Tofacitinib

Association of hepatic Meteorin-like and Krüppel-like factor 3 with weight loss after laporoscopic adjustable gastric banding

Liver and heart fibrosis develops simultaneously in patients with alcohol use disorder - a preliminary report of the HALFWAY study

Tillinger, W

Potential of managed care programmes for patients with inflammatory bowel diseases - results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASE_IBDstudy)

Corticosteroid therapy of flares in ulcerative colitis is less effective in patients with prior biologic therapy

Tischberger, L

Zöliakie: vom Symptom zur Diagnose

Traub, J

Gut Microbiome Dysbiosis, Bile acids, and Sarcopenia in Liver Cirrhosis

Trauner, M

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Neue Risikostratifizierung nach kolorektaler Polypektomie reduziert die Bürde an Nachsorekoloskopien ohne die Mortalität zu erhöhen

Assoziation der Adenomentdeckungsrate und Charakteristika abgetragener Adenome mit der Mortalität des kolorektalen Karzinoms nach einer Vordorgekoloskopie

Acute haemodynamic response to intravenous propranolol predicts decompensation and mortality in patients with cirrhosis

Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study

Immunoglobulin subtypes and complement levels exhibit distinct dynamics across advanced chronic liver disease stages and predict first or further decompensation

The link between bacterial translocation, systemic inflammation, and circulatory dysfunction in cirrhosis

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease

NSBB-associated VWF-decreases in decompensated cirrhosis indicate a reduced risk of further decompensation, ACLF, and death

Increasing ACE activity in liver disease impacts on fibrinolysis and inflammation - a potential link to COVID-19

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices

Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease

The impact of betablocker treatment on cancer prognosis in patients with advanced hepatocellular carcinoma receiving sorafenib treatment

Antibiotic therapy is associated with worse outcome in patients with hepatocellular carcinoma treated with sorafenib

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Covered TIPS improves renal function in patients with cirrhosis and ascites

Risk evaluation for acute kidney injury and acute-on-chronic liver failure via a blood-based biomarker panel in patients with cirrhosis

Trojan, J

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Troppmair, J

IL-37 - a regulation relevant cytokine in liver regeneration?

Ulmer, H

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Urak, C

Endoscopic ultrasound (EUS) dependent decision to perform endoscopic retrograde cholangiopancreatography (ERCP) in biliary pancreatitis without cholestasis on conventional imaging

Value of Hitachi Shear Wave Elastography (SWE) to rule-in and rule-out the presence of esophageal varices in patients with compensated advanced liver disease

The association of liver steatosis assessed by the controlled attenuated parameter and severity of liver disease with the presence of cirrhotic cardiomyopathy

Veloso, J

Landscape of biomarkers and actionable gene alterations in adenocarcinoma of GEJ and stomach - A real-world data analysis

Vermeire, S

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Vierziger, C

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Villesen, I

Von Willebrand Factor (VWF) propeptide levels are similarly accurate for assessing portal hypertension as compared to VWF antigen

Viveiros, A

The Phenotypic Spectrum of Patients with Genetic variants in Ceruloplasmin

Wagner, SA

Bone marker response to intravenous iron treatment - an in vitro model

Waidmann, O

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Waldmann, E

Neue Risikostratifizierung nach kolorektaler Polypektomie reduziert die Bürde an Nachsorekoloskopien ohne die Mortalität zu erhöhen

Assoziation der Adenomentdeckungsrate und Charakteristika abgetragener Adenome mit der Mortalität des kolorektalen Karzinoms nach einer Vordorgekoloskopie

Waldschmidt, D

Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY score

Wang, C

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Watanabe, M

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Watschinger, C

Safety and efficacy of the mRNA-1273 SARS-CoV-2 vaccine in a cohort of patients with inflammatory bowel disease

IL-37 - a regulation relevant cytokine in liver regeneration?

A risk variant within the ‘interferon induced with helicase C domain 1ʹ (IFIH1) gene render epithelial cells susceptible for microbial stimuli

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

COVID-19 vaccination in patients with autoimmune hepatitis

COVID19 vaccination in liver transplant recipients

Weber-Eibel, J

Combined use of endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) for evaluation of obstructive jaundice and distal biliary strictures

Endoscopic ultrasound (EUS) dependent decision to perform endoscopic retrograde cholangiopancreatography (ERCP) in biliary pancreatitis without cholestasis on conventional imaging

Factors affecting the diagnostic performance of EUS-guided sampling in solid pancreatic lesions by trainee endoscopists

Red-green-blue (RGB) profiling of pancreatic mass-elastographies: validation of a predictive model for non-invasive assessment of malignancy

Der Effekt einer chronischen Statintherapie auf das Risikoeiner post-ERCP Pankreatitis mit bzw. ohne rektaler periprozeduraler NSAR-Therapie

Weinzierl, J

Factor VIII/protein C ratio independently predicts liver-related events but does not reflect the hypercoagulable state in patients with advanced-chronic liver disease

Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease

Wernly, B

Gastroenterologist against the machine - opportunities and limitations of machine learning models for prediction of advanced adenoma

NAFLD is not independently associated with H. pylori in an Austrian screening collective

Wernly, S

Gastroenterologist against the machine - opportunities and limitations of machine learning models for prediction of advanced adenoma

NAFLD is not independently associated with H. pylori in an Austrian screening collective

PNPLA3 and TM6SF2 are neither associated with decreased cardiovascular nor increased liver-related mortality in the general population

Wewalka, F

Ustekinumab bei Colitis ulcerosa - Real-world experience

ERCP in Österreich: Hat die Zentrumsgröße Einfluss auf Erfolgs- und Komplikationsraten?

Perorale endoskopische Myotomie am Ordensklinikum Linz

Flexible endoskopische Therapie des Zenker Divertikels

Widau, R

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Wiedmer-Chaparro, R

Perorale endoskopische Myotomie am Ordensklinikum Linz

Wieser, V

Polyunsaturated fatty acids in a Western diet trigger TLR2-dependent Crohn’s-like enteritis in mice

Dietary-derived ω-3 and ω-6 polyunsaturated fatty acids induce metabolic enteritis as a fuel of Crohn’s disease

Wimmer, P

The association of liver steatosis assessed by the controlled attenuated parameter and severity of liver disease with the presence of cirrhotic cardiomyopathy

Winder, T

Antibody response to bnt162b2 mRNA vaccine in patients with IBD or chronic liver disease

Wittmann, A

The influence of gender on the risk factors of acute pancreatitis in northeastern Austria

Wolf, F

Covered transjugular intrahepatic portosystemic shunt improves hypersplenism-associated cytopenia in cirrhosis

Covered TIPS improves renal function in patients with cirrhosis and ascites

Wolf, M

Risk factors for and effects of persistent and severe hypophosphataemia following ferric carboxymaltose: Secondary analysis of randomised clinical trials

Wurzer, H

Covid-19 and gastrointestinal manifestations: A retrospective cohort study

Yen, C

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Yun, C

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Zandanell, S

PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center

Zanetto, A

Prediction of hepatocellular carcinoma after sustained virologic response in patients with compensated advanced chronic liver disease

Zhao, S

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Zhu, A

Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: interim results from an expansion cohort of the phase 3 REACH-2 study

Ziachehabi, A

Short-term outcome and safety of peroral endoscopic myotomy for treating achalasia in a university hospital in Austria

Outcomes and safety of endoscopic submucosa dissection at a university clinic in Austria

Perorale endoskopische Myotomie am Ordensklinikum Linz

Flexible endoskopische Therapie des Zenker Divertikels

Zoller, H

Risk factors for and effects of persistent and severe hypophosphataemia following ferric carboxymaltose: Secondary analysis of randomised clinical trials

The Phenotypic Spectrum of Patients with Genetic variants in Ceruloplasmin

Bone marker response to intravenous iron treatment - an in vitro model

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Update on the Austrian epidemiology of Hepatitis D Virus (HDV)

Zollner, A

Safety and efficacy of the mRNA-1273 SARS-CoV-2 vaccine in a cohort of patients with inflammatory bowel disease

COVID-19 Vakzin induzierte B- und T-Zell-Antwort bei medizinischen Fachkräften mit und ohne vorherige SARS-CoV-2 Infektion

Beeinflussung des intestinalen Mikrobioms durch ein Extrakt der schwarzen Holunderbeere - Ergebnisse der ELDERGUT Studie

COVID-19 vaccination in patients with autoimmune hepatitis

COVID19 vaccination in liver transplant recipients

Einfluss von Inflammation auf zelluläre und systemische Pharmakokinetik von Tofacitinib

Zschocke, J

Autosomal Dominant Familial Intestinal Varicosis and Polyposis coli is associated with Pathogenic Variants in NKX2.3

Öfner, D

IL-37 - a regulation relevant cytokine in liver regeneration?